Skip to main content
main-content

07-11-2017 | ACR/ARHP 2017 | Video

Biologic use during pregnancy poses no serious infection risk in infants

Lead author Christina Chambers outlines the findings of an investigation into the effects of biologic therapy in pregnant women with rheumatoid arthritis on the risk for opportunistic infections in the babies.

Read the accompanying news story

image credits